$1.6 Million NIH Cooperative Agreement Supports SIGA Broad Spectrum Antiviral Research Read more about $1.6 Million NIH Cooperative Agreement Supports SIGA Broad Spectrum Antiviral Research ST-246 Used to Treat Complications From Exposure to Recombinant Vaccinia Virus Read more about ST-246 Used to Treat Complications From Exposure to Recombinant Vaccinia Virus SIGA Technologies Inc. Approved for NASDAQ Global Market Listing Read more about SIGA Technologies Inc. Approved for NASDAQ Global Market Listing SIGA Technologies Receives a $3 Million Research Grant From the National Institutes of Health Read more about SIGA Technologies Receives a $3 Million Research Grant From the National Institutes of Health SIGA Reaches Next Stage in BARDA's RFP Bidding Process Read more about SIGA Reaches Next Stage in BARDA's RFP Bidding Process SIGA Technologies, Inc. to be Added to the Russell 3000(r) and Russell Global(r) Indices Read more about SIGA Technologies, Inc. to be Added to the Russell 3000(r) and Russell Global(r) Indices SIGA Completes Nonclinical Toxicology Studies Supporting Safety in Humans for ST-246(r) Read more about SIGA Completes Nonclinical Toxicology Studies Supporting Safety in Humans for ST-246(r) SIGA Proposal to Fund Work On Broad Spectrum Antiviral Selected for Award by Department of Defense Read more about SIGA Proposal to Fund Work On Broad Spectrum Antiviral Selected for Award by Department of Defense SIGA Technologies, Inc. to Present At the 2009 Noble Financial Fifth Annual Equity Conference Read more about SIGA Technologies, Inc. to Present At the 2009 Noble Financial Fifth Annual Equity Conference SIGA Technologies Submits Response to BARDA RFP Read more about SIGA Technologies Submits Response to BARDA RFP Pagination First page « First Previous page ‹ Previous … Page 18 Page 19 Page 20 Page 21 Current page 22 Page 23 Page 24 Page 25 Page 26 … Next page Next › Last page Last » Subscribe to
$1.6 Million NIH Cooperative Agreement Supports SIGA Broad Spectrum Antiviral Research Read more about $1.6 Million NIH Cooperative Agreement Supports SIGA Broad Spectrum Antiviral Research
ST-246 Used to Treat Complications From Exposure to Recombinant Vaccinia Virus Read more about ST-246 Used to Treat Complications From Exposure to Recombinant Vaccinia Virus
SIGA Technologies Inc. Approved for NASDAQ Global Market Listing Read more about SIGA Technologies Inc. Approved for NASDAQ Global Market Listing
SIGA Technologies Receives a $3 Million Research Grant From the National Institutes of Health Read more about SIGA Technologies Receives a $3 Million Research Grant From the National Institutes of Health
SIGA Reaches Next Stage in BARDA's RFP Bidding Process Read more about SIGA Reaches Next Stage in BARDA's RFP Bidding Process
SIGA Technologies, Inc. to be Added to the Russell 3000(r) and Russell Global(r) Indices Read more about SIGA Technologies, Inc. to be Added to the Russell 3000(r) and Russell Global(r) Indices
SIGA Completes Nonclinical Toxicology Studies Supporting Safety in Humans for ST-246(r) Read more about SIGA Completes Nonclinical Toxicology Studies Supporting Safety in Humans for ST-246(r)
SIGA Proposal to Fund Work On Broad Spectrum Antiviral Selected for Award by Department of Defense Read more about SIGA Proposal to Fund Work On Broad Spectrum Antiviral Selected for Award by Department of Defense
SIGA Technologies, Inc. to Present At the 2009 Noble Financial Fifth Annual Equity Conference Read more about SIGA Technologies, Inc. to Present At the 2009 Noble Financial Fifth Annual Equity Conference
SIGA Technologies Submits Response to BARDA RFP Read more about SIGA Technologies Submits Response to BARDA RFP